FIELD: medicine; pharmacology. SUBSTANCE: this composition includes 0.03000 to 0.04000 g of flacumine, 0.01000 to 0.02000 g of cystein, 0.00001 to 0.00002 g of sodium selenite, α = 0.01000 to 0.02000 g of tocopherol acetate, and 0.04000 to 0.05000 g of ascorbic acid. EFFECT: immunity of organism to stresses and prevention of atherosclerosis. 13 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR EARLY PATHOGENETIC THERAPY OF ACUTE RADIATION DISEASE | 2003 |
|
RU2281092C2 |
ANTI-ISCHEMIC AND ANTI-ATHEROSCLEROTIC DRUG | 1998 |
|
RU2144822C1 |
PREPARATION BEING OF LIPID-CORRECTING, HYPOCOAGULATIVE AND ANTIOXIDANT PROPERTIES | 2005 |
|
RU2302248C2 |
AGENT TO CORRECT STRESS CONDITIONS IN ANIMALS | 2009 |
|
RU2409347C1 |
PREPARATION FOR NORMALISATION OF LIPID PEROXIDATION PROCESSES IN ANIMALS | 2013 |
|
RU2538666C2 |
IMPROVEMENT OF FOOD STUFF BIOLOGICAL VALUE | 2004 |
|
RU2266683C1 |
DIETARY SUPPLEMENT (VERSIONS) | 2007 |
|
RU2352147C2 |
STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
METHOD OF TREATING ACNE | 2012 |
|
RU2495675C1 |
DIETARY SUPPLEMENT | 2007 |
|
RU2345571C2 |
Authors
Dates
1995-04-20—Published
1990-06-18—Filed